OBESITY, INSULIN RESISTANCE AND INCREASE IN ADIPOKINES LEVELS: IMPORTANCE, OF THE DIET AND PHYSICAL ACTIVITY

被引:0
作者
Rodriguez-Rodriguez, E. [1 ]
Perea, J. M. [1 ]
Lopez-Sobaler, A. M. [1 ]
Ortega, R. M. [1 ]
机构
[1] Univ Complutense Madrid, Fac Farm, Dept Nutr, E-28040 Madrid, Spain
关键词
Obesity; Diet; Physical activity; Insulin; NECROSIS-FACTOR-ALPHA; WHITE ADIPOSE-TISSUE; FREE FATTY-ACIDS; SYMPATHETIC-NERVOUS-SYSTEM; OXIDATIVE STRESS; ANGIOTENSIN-II; CARDIOVASCULAR-DISEASE; ENDOTHELIAL FUNCTION; LIPID-METABOLISM; RETINOIC ACID;
D O I
暂无
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
With obesity the amount of pro- and anti-inflammatory adipokines released is increased within the fat tissue. These molecules are implicated in many clinical manifestations of this pathology such as diabetes, arterial hypertension, or cardiovascular disease. At the first stage, the fat tissue of the obese patient becomes resistant to the action of insulin due to the effect of some of these adipokines such as tumour necrosis alpha (TNF-alpha) or interleukine-6 (IL-6). At a second stage, this resistance occurs at other tissues and glucose and insulin levels are increased. This increase, together with high adipokines levels (hat occur in diabetes, lead to the occurrence of different adverse events, such as the following: increase in oxidative stress, endothelial dysfunction, increase in blood pressure, and impairments in lipoprotein metabolism, all of which are harmful for health. Practising physical activity and following it balanced diet, similar to the Mediterranean pattern with low Fat and salt consumption, would be helpful for improving insulin resistance and adipokines levels in obese people, thus helping improving their health status in the long run.
引用
收藏
页码:415 / 421
页数:7
相关论文
共 80 条
[1]   Adipose tissue as an endocrine organ [J].
Ahima, RS ;
Flier, JS .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2000, 11 (08) :327-332
[2]   Human fat cell lipolysis: Biochemistry, regulation and clinical role [J].
Arner, P .
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 19 (04) :471-482
[3]   Plasminogen activator inhibitor (PAI)-1 in vascular inflammation and thrombosis [J].
Aso, Yoshimasa .
FRONTIERS IN BIOSCIENCE-LANDMARK, 2007, 12 :2957-2966
[4]   Upregulation of apolipoprotein B secretion, but not lipid, by tumor necrosis factor-α in rat hepatocyte cultures in the absence of extracellular fatty acids [J].
Bartolome, Nerea ;
Rodriguez, Lorena ;
Martinez, Maria J. ;
Ochoa, Begona ;
Chico, Yolanda .
SIGNAL TRANSDUCTION PATHWAYS, PT D: INFLAMMATORY SIGNALING PATHWAYS AND NEUROPATHOLOGY, 2007, 1096 :55-69
[5]   Immune-neuro-endocrine interactions: Facts and hypotheses [J].
Besedovsky, HO ;
DelRey, A .
ENDOCRINE REVIEWS, 1996, 17 (01) :64-102
[6]   Role of fatty acids in the pathogenesis of insulin resistance and NIDDM [J].
Boden, G .
DIABETES, 1997, 46 (01) :3-10
[7]   Free fatty acids in obesity and type 2 diabetes:: defining their role in the development of insulin resistance and β-cell dysfunction [J].
Boden, G ;
Shulman, GI .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2002, 32 :14-23
[8]  
Bonomini F, 2008, HISTOL HISTOPATHOL, V23, P381, DOI 10.14670/HH-23.381
[9]   ICAM-1 expression in adipose tissue: effects of diet-induced obesity in mice [J].
Brake, Danett K. ;
Smith, E. O'Brian ;
Mersmann, Harry ;
Smith, C. Wayne ;
Robker, Rebecca L. .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2006, 291 (06) :C1232-C1239
[10]   Leptin and hypertension in obesity [J].
Bravo, Paco E. ;
Morse, Stephen ;
Borne, David M. ;
Aguilar, Erwin A. ;
Reisin, Efrain .
VASCULAR HEALTH AND RISK MANAGEMENT, 2006, 2 (02) :163-169